Know the mechanism behind your bioactive — in 8 weeks.
BioSēq runs bulk RNA-seq on your nutritional ingredient in our C. elegans organism-on-chip, then maps the differentially expressed genes to human orthologs and pathways — turning a phenotype into actionable, human-relevant bio-intelligence.
Worm-to-human bio-intelligence
BioSēq™ provides mechanistic insight into the human-relevant genes and pathways modulated by your bioactive — mapping worm DEGs to their human orthologs and enriched pathways.
In vivo transcriptomics in weeks — not years.
Faster, cheaper, and ethical organism-on-chip for nutrition research
Protein-coding genes
Same number as humans, with 60–80% orthologs.
Whole-lifecycle in <4 weeks
One worm day maps to ~2.85 human years.
Fully transparent body
Every cell observable in real time under a microscope.
Proven model
Cell death, RNAi, GFP imaging, microRNA (2024).
From bioactive exposure to translational insight
Bioactive exposure
Your ingredient at a target dose, dosed to C. elegans on the Infinity Chip.
HT RNA-Seq
Bulk RNA-seq across three technical replicates.
Worm-to-human mapping
Worm DEGs mapped to human orthologs with a homology score.
Translational insights
Enriched human pathways and candidate health benefits.
Flown in space. Funded by NASA and the NIH. Peer-reviewed.
The organism-on-chip and in vivo transcriptomics platform behind BioSēq has been validated in orbit under federal funding and documented in the peer-reviewed literature.
BioSēq Academic Access — ASN 2026
What we need from you
An ingredient sample of 1–10 grams (amount depends on the target dose), the target dose, and basic solubility / vehicle information.
What you get back
DEGs, human orthologs, enriched pathways, gene-level roles by health area, and candidate clinical endpoints — a publication-ready readout in 8 weeks. See an example →